GLYCOS BIOTECHNOLOGIES

glycos-biotechnologies-logo

Glycos Biotechnologies, Inc. enables the fuels and chemicals industries of the future. Their partners can flexibly make high value products from a wide range of non-food feedstocks, increasing profits and reducing carbon footprint. They partner with ethanol companies, biodiesel companies and chemical companies interested in leveraging existing infrastructure into alternative chemicals and fuels production. They are also collaborating with biorefinery manufacturers and plant operators to deliver the technology for an integrated biorefinery solution.

#SimilarOrganizations #People #Financial #Website #More

GLYCOS BIOTECHNOLOGIES

Industry:
Biotechnology Chemical Renewable Energy

Founded:
2007-01-01

Address:
Houston, Texas, United States

Country:
United States

Website Url:
http://www.glycosbio.com

Total Employee:
11+

Status:
Active

Contact:
713-869-9377

Email Addresses:
[email protected]

Total Funding:
19.39 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content Google Apps For Business AJAX Libraries API Google Google Cloud


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

genomatica-logo

Genomatica

Genomatica manufactures sustainable chemicals from renewable feedstocks.

newlight-technologies-logo

Newlight Technologies

Newlight Technologies is a biotechnology company producing advanced sustainable materials.

codex-dna-logo

Codex DNA

Codex DNA is a biology company helping researchers with the tools they need to securely design, code, and create synthetic DNA.

zymochem-logo

Zymochem

Zymochem develop microbes & bioprocesses that enable profitable & eco-friendly production of chemicals from renewable sources such as sugar.


Current Advisors List

steve-jurvetson_image

Steve Jurvetson Member of Board of Directors @ Glycos Biotechnologies
Board_member

not_available_image

Walter S. Burnap Board Member @ Glycos Biotechnologies
Board_member

not_available_image

Gary Mossman Board Of Directors @ Glycos Biotechnologies
Board_member

dan-watkins_image

Dan Watkins Boards of Directors @ Glycos Biotechnologies
Board_member

Current Employees Featured

daniel-jmonticello_image

Daniel J.Monticello
Daniel J.Monticello Vice President, Research and Development @ Glycos Biotechnologies
Vice President, Research and Development

richard-c-cilento-jr_image

Richard C. Cilento, Jr.
Richard C. Cilento, Jr. CEO @ Glycos Biotechnologies
CEO
2016-01-01

not_available_image

Walter S. Burnap
Walter S. Burnap President and Chief Financial Officer @ Glycos Biotechnologies
President and Chief Financial Officer

werner-bussmann_image

Werner Bussmann
Werner Bussmann Vice President, Program Management @ Glycos Biotechnologies
Vice President, Program Management

kevin-dmitchell_image

Kevin D.Mitchell
Kevin D.Mitchell Vice President, Finance @ Glycos Biotechnologies
Vice President, Finance

Founder


ramon-gonzalez_image

Ramon Gonzalez

Investors List

texas-halo-fund_image

Texas HALO Fund

Texas HALO Fund investment in Seed Round - Glycos Biotechnologies

dfj-mercury-894f_image

DFJ Mercury

DFJ Mercury investment in Debt Financing - Glycos Biotechnologies

threshold_image

Threshold

Threshold investment in Debt Financing - Glycos Biotechnologies

dfj-mercury-894f_image

DFJ Mercury

DFJ Mercury investment in Debt Financing - Glycos Biotechnologies

eiv-capital_image

EIV Capital

EIV Capital investment in Series B - Glycos Biotechnologies

dfj-mercury-894f_image

DFJ Mercury

DFJ Mercury investment in Series B - Glycos Biotechnologies

dnx-ventures_image

DNX Ventures

DNX Ventures investment in Series B - Glycos Biotechnologies

threshold_image

Threshold

Threshold investment in Series B - Glycos Biotechnologies

gideon-hixon-fund_image

Gideon Hixon Fund

Gideon Hixon Fund investment in Series B - Glycos Biotechnologies

threshold_image

Threshold

Threshold investment in Series A - Glycos Biotechnologies

Official Site Inspections

http://www.glycosbio.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Glycos Biotechnologies" on Search Engine